Kott JM, Mooney-Leber SM, Shoubah FA, Brummelte S
Researchers may need to consider which receptor pathways are being reviewed, what laboratory model is being used, how observations are measured and how findings are interpreted within a controlled research context
First, GLP-1 causes an increase in satiety and a decrease in hunger leading to decreased food intake [11]
Read clinical review Clinical Reviews GIP/GLP-1 Dual Agonists: Special-Populations Prescribing Summary Evidence-based prescribing guide for tirzepatide and other GIP/GLP-1 dual agonists in renal impairment, hepatic disease, older adults, adolescents, pregnancy, and heart failure with preserved ejection fraction
It is also important to consider how semaglutide interacts with allergy medications